Funding Search - Pivot

The University of Vermont, through Sponsored Project Administration (SPA) subscribes to Pivot, a web-based funding search tool. The UVM Cancer Center has collaborated with SPA to create a customized cancer relevant pivot search. Press the button for Cancer Funding Opportunities.

Cancer Funding Opportunities

If you would prefer to set up your own pivot search and automated alerts you can learn more about pivot HERE.

For Pivot Assistance

Please review the information provided by SPA

Hilda Alajajian, Grant Resources Specialist is available to meet with individuals or groups for assistance in identifying funding

Phone: (802)656-1322

Should you learn of an opportunity not listed here but important to UVM Cancer Center research, please contact Laura Gordon.


Limited Competition Funding

Please contact Edward North for information on applying for Limited Funding Opportunities. 

Peer-Reviewed Funding Sources

Below is a list of fund sources from federal agencies, non-profit foundations and regional and national organizations to support cancer research are provided below for UVM Cancer Center researchers. This of funding is considered NCI approved peer-reviewed funding and can also be found in PDF format at the following link: NCI Peer-Reviewed Fund Sources


  1. Agency for Healthcare Research and Quality (AHRQ)
  2. Alex’s Lemonade Stand Foundation (ALSF)
  3. American Association of Cancer Research (AACR)
  4. American Cancer Society (ACS) (national office only)
  5. American Foundation for AIDS Research (amfAR)
  6. American Institute for Cancer Research (AICR)
  7. California Institute for Regenerative Medicine (CIRM)
  8. Cancer Prevention Research Institute of Texas (CPRIT)
  9. Center for Disease Control and Prevention (CDC)
  10. Central Office of the Veterans Administration (VA) (excluding local/regional & “block” grants)
  11. Environmental Protection Agency (EPA)
  12. The Flight Attendant Medical Research Institute (FAMRI)
  13. Florida Biomedical Research Program (FBRP)
  14. Food and Drug Administration (FDA)
  15. Howard Hughes Medical Institute (HHMI)
  16. Leukemia and Lymphoma Society (LLS)
  17. Melanoma Research Alliance (MRA)
  18. Multiple Myeloma Research Foundation (MMRF)
  19. National Institute for Occupational Safety and Health (NIOSH)
  20. National Science Foundation (NSF)
  21. New York State Department of Health Wadsworth Center/New York State Stem Cell Science Program (NYSTEM)
  22. Patient-Centered Outcomes Research Institute (PCORI)
  23. Prevent Cancer Foundation (PCF)
  24. Prostate Cancer Foundation (PCF)
  25. Susan G. Komen for the Cure
  26. The California Breast Cancer Research Program (CBCRP)
  27. The California Tobacco Related Disease Research Program (TRDRP)
  28. U.S. Army (DOD) special research programs *

Highlights: New & Updated

New and Updated

NCI/NIH PAR-18-911 - Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed) - "National Cancer Institute (NCI) invites P20 planning grant applications for developing collaborative partnership between institutions serving underserved health disparity populations and underrepresented students (ISUPS) and NCI- designated Cancer Centers (or Cancer Centers with highly integrated cancer research programs). This FOA is designed to facilitate the planning and execution of focused collaborations in cancer-related research, research experience, and research education. A major goal of the NCI P20 partnership programs is to provide support for investigators at ISUPS and Cancer Centers to conduct cancer research pilot projects and cancer research education program. The purpose of the pilot projects and education program is to allow awardees to obtain preliminary data that will lead to competitive grant applications for funding by the NIH/NCI and/or other Federal/Non-Federal agencies. This FOA will utilize the NIH P20 Exploratory Grants award mechanism." 

Funding Amount: $1,500,000

Deadline: 11/13/2019

American Association for Cancer Research - Gertrude B. Elion Cancer Research Award  - "The AACR Gertrude B. Elion Cancer Research Award provides a one-year grant of $75,000 to encourage and support tenure-eligible junior faculty. The research proposed for funding must focus on research in cancer etiology, diagnosis, treatment, or prevention and may be basic, translational, or clinical in nature"

Funding Amount: $75,000

Deadline: 11/21/2019
Rivkin Center for Ovarian Cancer - Scientific Scholar Award - Two-year grants at $120,000 each, Scientific Scholar Awards are intended to assist promising laboratory and clinical scientists in pursuing a career as an independent investigator in ovarian cancer research. Deadline December 02, 2019.

NIH - PAR-18-950 “Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)” - "The X02 pre-application is the highly-recommended first step in the U01 cooperative agreement application process. This program is aimed to support extramural-intramural collaborative, “patient-centric translational” research projects that enhance the translation of promising laboratory- and animal-based discoveries into clinical applications for improved disease diagnosis, treatment and prevention by taking advantage of the unique research opportunities available at the NIH Clinical Center (https://www.cc.nih.gov/translational-research-resources/resources.html). Specifically, this program promotes partnerships between the NIH intramural investigators and extramural investigators, and provides support for extramural investigators to conduct clinical research projects at the NIH Clinical Center in collaboration with the NIH intramural investigators. The National Cancer Institute (NCI) encourages well-balanced extramural-intramural contributions towards accomplishing the proposed Aims for the intellectually-challenging collaborative projects."

Application Due: 12/11/2019

NIH - PAR-18-951 "Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)" - "The goal of this program is to support collaborative translational research projects aligned with NIH efforts to enhance the translation of basic biological discoveries into clinical applications that improve health.  It encourages high quality science demonstrating the potential to result in understanding an important disease process or lead to new therapeutic interventions, diagnostics, or prevention strategies within the research interests and priorities of the participating NIH Institutes/Centers (ICs).

Specifically, the program seeks to broaden and strengthen translational research collaborations between basic and clinical researchers both within and outside NIH to accelerate and enhance translational science by promoting partnerships between NIH intramural investigators (e.g., those conducting research within the labs and clinics of the NIH) and extramural investigators (e.g., those conducting research in labs outside the NIH), and by providing support for extramural investigators to take advantage of the unique research opportunities available at the NIH Clinical Center by conducting clinical research projects in collaboration with NIH intramural investigators."

Application Due: April 15, 2020